65283-97-8

Basic information

• Product Name: 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE
• Synonyms: 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE;5-isopropyl-1,3,4-oxadiazol-2-amine(SALTDATA: FREE);(5-isopropyl-1,3,4-oxadiazol-2-yl)amine;5-propan-2-yl-1,3,4-oxadiazol-2-amine;1,3,4-Oxadiazol-2-amine,5-(1-methylethyl)-
• CAS NO: 65283-97-8
• Molecular Formula: C₅H₉N₃O
• Molecular Weight: 127.15
• Mol File: 65283-97-8.mol
• Article Data: 6

Chemical Properties

• Melting Point: 182-183 °C
• Boiling Point: 236.41°C at 760 mmHg
• Flash Point: 96.778°C
• Appearance: /
• Density: 1.145g/cm³
• Vapor Pressure: 0.047mmHg at 25°C
• Refractive Index: 1.509
• PKA: -0.52±0.13(Predicted)
• CAS DataBase Reference: 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE(65283-97-8)
• EPA Substance Registry System: 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE(65283-97-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 65283-97-8(Hazardous Substances Data)

Usage

General Description

5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE, also known as 2-Amino-5-isopropyl-1,3,4-oxadiazole, is a chemical compound with the molecular formula C5H10N4O. It is a derivative of oxadiazole and contains an isopropyl group. 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE is used in various industrial applications, including in the production of pharmaceuticals and agrochemicals. It is also used as a building block in organic synthesis and as a reagent in chemical research. The chemical structure and properties of 5-ISOPROPYL-1,3,4-OXADIAZOL-2-AMINE make it a versatile and valuable compound in the field of organic chemistry.

InChI:InChI=1/C5H9N3O/c1-3(2)4-7-8-5(6)9-4/h3H,1-2H3,(H2,6,8)

Upstream product

• 592-64-3 2-Methylpropanal Semicarbazon 
• 506-68-3 bromocyane 
• 3619-17-8 isobutyric acid hydrazide 

Downstream Products

• 6694-35-5 1-(5-isopropyl-[1,3,4]oxadiazol-2-yl)-3-phenyl-urea 

Relevant articles and documents

ANTIBIOTIC COMPOUNDS

The present invention relates to antibiotic compounds of formula (I), to compositions containing these compounds and to methods of treating bacterial diseases and infections using the compounds. The compounds find application in the treatment of infection with, and diseases caused by, Gram-positive and/or Gram-negative bacteria, and in particular in the treatment of infection with, and diseases caused by, Neisseria gonorrhoeae.

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS

-